title: Markers of health status in an HTLV-I-positive cohort.
abstract: The health effects of chronic human T-cell lymphotropic virus type I (HTLV-I) infection were examined in a cohort of Japanese men who had emigrated from Okinawa, Japan, and had been participants in a prospective study in Hawaii since 1965. In the present follow-up study carried out in 1987-1988, various health indicators were measured in the subjects, whose mean age was 72.5 years. Participation rates were lower in the HTLV-I seropositives than in the seronegatives (46.7% vs. 76.0%) in the > or = 75-year age group. Lack of participation was significantly correlated with a high HTLV-I antibody titer. Among the participants, seropositive subjects were significantly more likely than the seronegatives to have lymphocytopenia (32.7% vs. 17.7%) and mild anemia (25.5% vs. 14.1%) after adjustment for age and socioeconomic status. The seropositives also had a higher frequency of acupuncture therapy (age-adjusted odds ratios were 2.1 and 4.2 for 1-5 treatments and > or = 6 treatments, respectively). Proportions of subjects who had been hospitalized at least twice were higher among the seropositives in the oldest age groups, 70-74 years and > or = 75 years, but not in those aged 65-69 years. Although specific disease conditions were not identified in this study, hematologic data, treatment histories, and the correlation between participation status and HTLV-I antibody titers suggest that chronic HTLV-I infection may be associated with as yet undefined adverse health effects, particularly in older age groups.
authors: Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD.
authors: G Y
authors: GY
authors: Ho
authors: K
authors: K
authors: Nelson
authors: A M
authors: AM
authors: Nomura
authors: B F
authors: BF
authors: Polk
authors: W A
authors: WA
authors: Blattner
mesh_terms: D015670:Acupuncture Therapy / Q000706:statistics & numerical data; D000367:Age Factors; D000368:Aged; D000740:Anemia / Q000453:epidemiology* / Q000209:etiology; D000914:Antibodies, Viral / Q000097:blood; D001772:Blood Cell Count; D004522:Educational Status; D004641:Emigration and Immigration; D005500:Follow-Up Studies; D015490:HTLV-I Infections / Q000097:blood / Q000150:complications / Q000453:epidemiology*; D006254:Hawaii / Q000453:epidemiology; D006305:Health Status Indicators; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007564:Japan / Q000208:ethnology; D008231:Lymphopenia / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D017533:Marital Status; D010358:Patient Participation; D011446:Prospective Studies; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D012959:Socioeconomic Factors
chemical_list: D000914:Antibodies, Viral